1[1] Giorgio B, Mario A, Mauro B, et al. A new rational hypothesis for the pharmacophore of the active metabolite of leflunomide, a potent immunosuppressive drug[J]. J Med Chem, 1997, 40(13): 2011-2016.
3[3] Elizabeth AK, Philip TH, David PK, et al. Synthesis, structure-activity relationships, and pharmacokinetic properties of dihydroorotata dehydrogenase inhibitors: 2-cyano-3-cyclopropyl-3-hydroxy-N-[3'-methyl-4'-(trifluoromethyl) phenyl] propenamide and related compounds[J]. J Med Chem, 1996, 39(23): 4608-4621.
4[4] Kaemmerer FJ, Schleyerbach R. Isoxazole derivative[P]. DE: 2854439, 1980-07-03. (CA 1980, 93: 239392 m)
6Pitero S, Paola F,Giulia M.with dinucleophiles.X. Synthesis of 5-subsitituted ethyl or methy 4-isoxazolecarboxylates and methy 4-(2,2-dimethyl-1-oxopropyl)-5-isoxazolecarboxylate [J], J Heterocycl Chem,1991, 28: 453～457.
7Hiroyuki Y. Studies on the synthesis of 4,5-disubstituted isaoxazoles and their cleavage reaction with sodium ethoxide III. Structure of isoxazole compound derived from ethyl 2- formylacetoacetate[J]. Yakugaku Zasshi, 1959,79(6): 836-838.
8Doleshall G, Seres R Isoxazole-oxazole conversion by Beckmann rearrangement[J]. J Chem Soc, Perkin Trans I, 1988(7): 1875- 1879.
9Giulia M,Lusia M,Pitero S. Reaction of 2-dimethylaminomethylene-1,3-diones with dinucleophiles VI. Synthesis of ethyl or methyl 1,5-disubstituted 1H-pyrazole--4-carboxylates [J]. J Heterocyclic Chem, 1987,24: 1669-1675.
10Gallagher P T, Hicks T A, Mullier G W. N-Phenyl butenamides with pharmaceutical properties: EP, 0257882 [P].1988-03-02.
